RDHL News and Press, Redhill Biopharma Ltd. From 07/21/23

RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development PR Newswire Opaganib awarded a further $1.7 million in U.S. Government funding for development as a medical countermeasure for gastrointestinal acute radiation syndrome (AR...

2023-07-19 10:22:17 ET Gainers: Panbela Therapeutics ( PBLA ) +36% . 60 Degrees Pharmaceuticals ( SXTP ) +20% . CareMax ( CMAX ) +20% . Biodexa Pharmaceuticals ( BDRX ) +13% . bluebird bio ( BLUE ) +13% . Losers: Amar...

2023-07-14 13:00:55 ET Gainers: Knightscope ( KSCP ) +27% . Chijet Motor Company ( CJET ) +28% . Apogee Therapeutics APGE +27% . RedHill Biopharma ( RDHL ) +32% . Envirotech Vehicles ( EVTV ) +26% . Canoo ( GOEV ) +25% . ...

2023-06-12 08:54:37 ET RedHill press release ( NASDAQ: RDHL ): Q1 GAAP EPS of -$0.05. Revenue of $3.6M (-71.9% Y/Y). Net Income for the first quarter of 2023 was $50.2 million, as compared to Net Loss of $3.7 million for the fourth quarter of 2022, Total Assets as ...

RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights PR Newswire Q1/23 Talicia net revenues of $3.4 million ; Cash balance of $28.8 million as of March 31, 2023 [1] ; Extinguishment of all debt obligations in exchange for the...

RedHill Provides R&D Update RedHill Provides R&D Update PR Newswire RedHill has elected to terminate RHB-204's U.S. Phase 3 study for Non-tuberculosis Mycobacteria (NTM) disease due to low accrual rate and plans to shift resources to more rapidly advance RHB-10...

2023-05-16 05:33:39 ET RedHill Biopharma ( NASDAQ: RDHL ) received a notice from Nasdaq for not being in compliance with the rule of minimum $15M market value of shares for continued listing on the exchange. The Israeli company said it has 180 calendar days, or ...

RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , May 15, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company...

RedHill Publishes New Talicia® Data on Generic Non-Bioequivalence in AP&T and Presents New Dosing Data at Digestive Disease Week RedHill Publishes New Talicia® Data on Generic Non-Bioequivalence in AP&T and Presents New Dosing Data at Digestive Disease Week PR News...

RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting PR Newswire European Patent Office grants RHB-102 patent covering antiemetic extended-release solid dosage forms for the prevention of nausea and vomiting (CINV/RINV), providing protection o...